Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
Emergency War Surgery
Second United States Revision of The Emergency War Surgery NATO Handbook
United States Department of Defense

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

Emergency War Surgery NATO Handbook: Part II: Response of the Body to Wounding: Chapter XI: Infection

Table 7

United States Department of Defense


Table 7. - Choice, Mode of Action, Spectrum, and Dosage of Antibiotic Agents

Agent

Mode of Action

Antibacterial Spectrum of Clinical Importance

Dosage

Penicillin G

Bactericidal; interferes with bacterial cell wall synthesis

Streptococci, Pneumococci Clostridia, Neisseriae, Corynebacteria, Pasteurella multocida, Actinomyces, Treponema, Listeria

30 mil units IV/day every 2-4 hours

Ampicillin

Bactericidal; same as above

Hemophilus influenzae, Proteus mirabilis, Salmonallae, Shigellae and some E. coli. Gram-positive organisms as with Penicillin G

8 gm IV/day every 6 hours

Gentamicin

Bacteriostatic; inhibition of bacterial protein synthesis

Klebsiella sp., Aerobacter sp., Pseudomonas aeruginosa, Serratia, indole positive Proteus sp., some Methicillin-resistant Staphylococci

5 mg/kg/day every 8-12 hours

Metronidazole

Bacteriocidal

Gram-negative anaerobes especially Bacteriodes fragilis. Also effective against several protozoa.

2 gm IV/day every 4 hours

Cefoxitin (2nd generation cephalosporin)

Cell wall synthesis inhibitors; stable to staphylococcal beta lactamases

Same as above plus Bacteroides fragilis; not active against Enterobacter spp.

12 gm IV/day every 6 hours

Clindamycin

Bacteriostatic; inhibits protein synthesis

Gram-positive and Gram-negative anaerobes, Gram-positive aerobic cocci, Streptococcus faecalis, Clostridia

1200-2700 mg IV/day every 6-8 hours

 

 

 


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products

 

Advertise on this site